PURPOSE
To compare the 5-year outcomes of the Ahmed FP7 Glaucoma Valve (AGV) (New World Medical, Cucamonga, CA) and the Baerveldt 101-350 Glaucoma Implant (BGI) (Abbott Medical Optics, Abbott Park, IL) for the treatment of refractory glaucoma.
DESIGN
Multicenter, randomized, controlled clinical trial.
PARTICIPANTS
A total of 276 patients, including 143 in the AGV group and 133 in the BGI gr...